These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 24258459)
21. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer. Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108 [TBL] [Abstract][Full Text] [Related]
22. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer. Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474 [TBL] [Abstract][Full Text] [Related]
23. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma. Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of the Receptor for Advanced Glycation Endproducts (RAGE) is associated with poor prognosis in gastric cancer. Wang D; Li T; Ye G; Shen Z; Hu Y; Mou T; Yu J; Li S; Liu H; Li G PLoS One; 2015; 10(4):e0122697. PubMed ID: 25860956 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer. Liu Y; Deng J; Luo X; Pan Y; Zhang L; Zhang R; Liang H Med Oncol; 2015 Jan; 32(1):404. PubMed ID: 25471787 [TBL] [Abstract][Full Text] [Related]
26. CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival. He WP; Zhou J; Cai MY; Xiao XS; Liao YJ; Kung HF; Guan XY; Xie D; Yang GF BMC Cancer; 2012 Sep; 12():437. PubMed ID: 23020525 [TBL] [Abstract][Full Text] [Related]
27. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748 [TBL] [Abstract][Full Text] [Related]
28. CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer. Zhang XG; Song BT; Liu FJ; Sun D; Wang KX; Qu H Clin Transl Oncol; 2016 Jul; 18(7):700-7. PubMed ID: 26489425 [TBL] [Abstract][Full Text] [Related]
29. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis. Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204 [TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer. Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593 [TBL] [Abstract][Full Text] [Related]
31. The high expression of CHD1L and its clinical significance in human solid tumors: A meta-analysis. Zhang L; Jiang Y; Jiao P; Deng X; Xie Y Medicine (Baltimore); 2021 Mar; 100(10):e24851. PubMed ID: 33725840 [TBL] [Abstract][Full Text] [Related]
32. Overexpression of BCAT1 is a prognostic marker in gastric cancer. Xu Y; Yu W; Yang T; Zhang M; Liang C; Cai X; Shao Q Hum Pathol; 2018 May; 75():41-46. PubMed ID: 29447920 [TBL] [Abstract][Full Text] [Related]
33. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer. Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316 [TBL] [Abstract][Full Text] [Related]
34. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer. Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914 [TBL] [Abstract][Full Text] [Related]
35. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma. Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878 [TBL] [Abstract][Full Text] [Related]
36. CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2. He WP; Guo YY; Yang GP; Lai HL; Sun TT; Zhang ZW; Ouyang LL; Zheng Y; Tian LM; Li XH; You ZS; Xie D; Yang GF Int J Med Sci; 2020; 17(15):2387-2395. PubMed ID: 32922205 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and prognostic significance of aberrant G protein-couple receptor 110 (GPR110) expression in gastric cancer. Zhu X; Huang G; Jin P Pathol Res Pract; 2019 Mar; 215(3):539-545. PubMed ID: 30638950 [TBL] [Abstract][Full Text] [Related]
38. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer. Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221 [TBL] [Abstract][Full Text] [Related]
39. Increased expression of FOXQ1 is a prognostic marker for patients with gastric cancer. Liang SH; Yan XZ; Wang BL; Jin HF; Yao LP; Li YN; Chen M; Nie YZ; Wang X; Guo XG; Wu KC; Ding J; Fan DM Tumour Biol; 2013 Oct; 34(5):2605-9. PubMed ID: 23609035 [TBL] [Abstract][Full Text] [Related]
40. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients. Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]